Narendra M. Dixit - researchr alias

researchr

You are not signed in
Sign in
Sign up

Viewing Publication 1 - 16 from 16

2025

Leveraging large language models for pandemic preparednessNarendra M. Dixit. ncs, 5(6):438-439, June 2025. [doi]

2024

Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo dataBharadwaj Vemparala, Vincent Madelain, Caroline Passaes, Antoine Millet, Véronique Avettand-Fenoel, Ramsès Djidjou Demasse, Nathalie Dereuddre-Bosquet, Roger Le Grand, Christine Rouzioux, Bruno Vaslin, Asier Sáez-Cirión, Jérémie Guedj, Narendra M. Dixit. ploscb, 20(9):1012434, 2024. [doi]

2022

Modeling how antibody responses may determine the efficacy of COVID-19 vaccinesPranesh Padmanabhan, Rajat Desikan, Narendra M. Dixit. ncs, 2(2):123-131, 2022. [doi]

2021

An efficient and scalable top-down method for predicting structures of microbial communitiesAamir Faisal Ansari, Yugandhar B. S. Reddy, Janhavi Raut, Narendra M. Dixit. ncs, 1(9):619-628, 2021. [doi]

Concerted Interactions between Multiple gp41 Trimers and the Target Cell Lipidome May Be Required for HIV-1 EntryBiswajit Gorai, Anil Kumar Sahoo, Anand Srivastava, Narendra M. Dixit, Prabal K. Maiti. jcisd, 61(1):444-454, 2021. [doi]

2020

Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infectionRajat Desikan, Rubesh Raja, Narendra M. Dixit. ploscb, 16(8), 2020. [doi]

Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infectionPranesh Padmanabhan, Rajat Desikan, Narendra M. Dixit. ploscb, 16(12), 2020. [doi]

Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infectionAnanya Saha, Narendra M. Dixit. ploscb, 16(11), 2020. [doi]

2018

Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agentsVipul Gupta, Narendra M. Dixit. ploscb, 14(2), 2018. [doi]

Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infectionVishnu Venugopal, Pranesh Padmanabhan, Rubesh Raja, Narendra M. Dixit. ploscb, 14(7), 2018. [doi]

2012

A Finite Population Model of Molecular Evolution: Theory and ComputationNarendra M. Dixit, Piyush Srivastava, Nisheeth K. Vishnoi. jcb, 19(10):1176-1202, 2012. [doi]

Stochastic Simulations Suggest that HIV-1 Survives Close to Its Error ThresholdKushal Tripathi, Rajesh Balagam, Nisheeth K. Vishnoi, Narendra M. Dixit. ploscb, 8(9), 2012. [doi]

2011

Ribavirin-Induced Anemia in Hepatitis C Virus Patients Undergoing Combination TherapySheeja M. Krishnan, Narendra M. Dixit. ploscb, 7(2), 2011. [doi]

Mathematical Model of Viral Kinetics In Vitro Estimates the Number of E2-CD81 Complexes Necessary for Hepatitis C Virus EntryPranesh Padmanabhan, Narendra M. Dixit. ploscb, 7(12), 2011. [doi]

2009

Timing the Emergence of Resistance to Anti-HIV Drugs with Large Genetic BarriersPankhuri Arora, Narendra M. Dixit. ploscb, 5(3), 2009. [doi]

2007

Emergence of Recombinant Forms of HIV: Dynamics and ScalingGajendra W. Suryavanshi, Narendra M. Dixit. ploscb, 3(10), 2007. [doi]

Sign in or sign up to see more results.

runs on WebDSL